PHS
COR icon

PFM Health Sciences’s Cencora COR Stock Holding History

PFM Health Sciences’s Portfolio COR Stock Details COR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-80,493
Closed -$25.2M – 84
2025
Q3 		$25.2M Buy
80,493
+27,206
+51% +$8.01M 1.93% 14
2025
Q2 		$16M Buy
+53,287
New +$15.4M 1.36% 23
2020
Q2 		– Sell
-338,732
Closed -$30M – 83
2020
Q1 		$30M Buy
+338,732
New +$29.8M 2.46% 17

Other funds holding COR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

PFM Health Sciences's COR Position: Q4 2025 in Review

PFM Health Sciences sold out of Cencora (COR) in Q4 2025, closing a stake of 80,493 shares — an estimated $25.2M sold.

PFM Health Sciences first reported a position in COR in Q1 2020 and held it in 3 quarters. The position peaked at $30M in Q1 2020. 1,467 funds tracked by Wall St. Rank hold COR as of Q4 2025.

  • PFM Health Sciences reported no remaining Cencora position as of Q4 2025 after selling out during the quarter.
  • PFM Health Sciences sold 80,493 Cencora shares in Q4 2025, an estimated $25.2M.
  • PFM Health Sciences first reported a position in Cencora in Q1 2020 and held it in 3 quarters.
  • PFM Health Sciences's Cencora position peaked at $30M in Q1 2020.
  • 1,467 funds tracked by Wall St. Rank held Cencora as of Q4 2025.

Based on PFM Health Sciences's 13F filing for Q4 2025, filed 17 Feb 2026.